ADEM hastalığı neden olur?

Akut dissemine ensefalomyelit (ADEM), santral sinir sisteminin akut başlangıçlı, değişken klinik seyir gösteren demyelinizasyonla karakterize bir hastalığıdır. Genellikle hastalığın başlangıcını tetikleyen viral enfeksiyonlar veya aşılardır.
ADEM virüsü nedir?
Akut dissemine ensefalomyelit (ADEM), aşılama ya da sistemik bir enfeksiyondan 1-3 hafta son- ra gelişen beyin parankimi ve spinal kordun yay- gın demiyelinizasyonu ile seyreden inflamatuar bir hastalıktır [1]. Klinik başvuru genellikle ateş, baş ağrısı, miyalji, bulantı, kusma gibi sistemik bulgu- ları takiben hızlı …
What is the prognosis of Adem?
ADEM can recur, usually within months of the initial diagnosis, and is treated by restarting corticosteroids. A small fraction of individuals who are initially diagnosed as having ADEM can go on to develop MS, but there is currently no method or known risk factors to predict whom those individuals will be.

Where can I find research related to Adem?

The National Institute of Neurological Disorders and Stroke (NINDS) and other institutes of the National Institutes of Health (NIH) conduct research related to ADEM in laboratories at the NIH, and also support additional research through grants to major medical institutions across the country.
What are the treatment options for Adem?
In rare situations, a brain biopsy may be necessary to differentiate between ADEM and some other diseases that involve inflammation and damage to myelin. Treatment for ADEM is targeted at suppressing inflammation in the brain using anti-inflammatory drugs.
What are the signs and symptoms of Adem?
ADEM often follows viral or bacterial infections, or less often, vaccination for measles, mumps, or rubella. The symptoms of ADEM appear rapidly, beginning with encephalitis-like symptoms such as fever, fatigue, headache, nausea and vomiting, and in the most severe cases, seizures and coma.